D. M. Pierce

The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist.

J Upward, Blake Arnold, C.G.G. Link et al. · PubMed · 1990 · 72 citations

Medicine, Pharmacology, Pharmacotherapy +8

The pharmacokinetics of indoramin and 6-hydroxyindoramin in poor and extensive hydroxylators of debrisoquine

D. M. Pierce, Stephen Smith, Richard A. Franklin · European Journal of Clinical Pharmacology · 1987 · 28 citations

Pharmacy, Pharmacokinetics, Pharmacology +3

The tolerance to and pharmacokinetics of penciclovir (BRL 39123A), a novel antiherpes agent, administered by intravenous infusion to healthy subjects

S. E. Fowled, D. M. Pierce, William Prince et al. · European Journal of Clinical Pharmacology · 1992 · 26 citations

Medicine, Pharmacokinetics, Pharmacology +8

Pharmacokinetics and tolerability of ascending intravenous doses of granisetron, a novel 5-HT3 antagonist, in healthy human subjects

A. Allen, C.C. Asgill, D. M. Pierce et al. · European Journal of Clinical Pharmacology · 1994 · 22 citations

Medicine, Pharmacokinetics, Pharmacology +8

Granisetron as antiemetic therapy in children with cancer

Alan Craft, L Price, O. B. Eden et al. · Medical and Pediatric Oncology · 1995 · 22 citations

Pharmacy, Pharmacology, Pharmacotherapy +10